Seroatlas · Human Serome Atlas

TRMU

Mitochondrial tRNA-specific 2-thiouridylase 1

Also known as: FLJ10140, MTO2, MTU1, MTU1_HUMAN, TRMT

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O75648
Gene
TRMU
Ensembl
ENSG00000100416
Chromosome
22
Canonical length
421 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Mitochondria

OverviewNCBI Gene

This nuclear gene encodes a mitochondrial tRNA-modifying enzyme. The encoded protein catalyzes the 2-thiolation of uridine on the wobble positions of tRNA(Lys), tRNA(Glu), and tRNA(Gln), resulting in the formation of 5-taurinomethyl-2-thiouridine moieties. Mutations in this gene may cause transient infantile liver failure. Polymorphisms in this gene may also influence the severity of deafness caused by mitochondrial 12S ribosomal RNA mutations. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]

Canonical amino-acid sequenceUniProt

421 residues, UniProt reviewed canonical sequence.

>O75648|TRMU
     1  MQALRHVVCA LSGGVDSAVA ALLLRRRGYQ VTGVFMKNWD SLDEHGVCTA DKDCEDAYRV
    61  CQILDIPFHQ VSYVKEYWND VFSDFLNEYE KGRTPNPDIV CNKHIKFSCF FHYAVDNLGA
   121  DAIATGHYAR TSLEDEEVFE QKHVKKPEGL FRNRFEVRNA VKLLQAADSF KDQTFFLSQV
   181  SQDALRRTIF PLGGLTKEFV KKIAAENRLH HVLQKKESMG MCFIGKRNFE HFLLQYLQPR
   241  PGHFISIEDN KVLGTHKGWF LYTLGQRANI GGLREPWYVV EKDSVKGDVF VAPRTDHPAL
   301  YRDLLRTSRV HWIAEEPPAA LVRDKMMECH FRFRHQMALV PCVLTLNQDG TVWVTAVQAV
   361  RALATGQFAV FYKGDECLGS GKILRLGPSA YTLQKGQRRA GMATESPSDS PEDGPGLSPL
   421  L

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TRMU can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
16 nTPM

Expression across tissuesHPA

Tissue

  • heart muscle: 16 nTPM
  • liver: 14 nTPM
  • midbrain: 11 nTPM
  • kidney: 11 nTPM
  • spinal cord: 11 nTPM
  • adrenal gland: 11 nTPM

Single-cell type

  • cardiomyocytes: 63 nCPM
  • distal convoluted tubule cells: 44 nCPM
  • myonuclei: 41 nCPM
  • cone photoreceptor cells: 39 nCPM
  • proximal tubule cells: 36 nCPM
  • corticotrophs: 36 nCPM

Immune cell

  • T-reg: 11 nTPM
  • non-classical monocyte: 9.9 nTPM
  • gdT-cell: 9.5 nTPM
  • memory CD8 T-cell: 9.1 nTPM
  • intermediate monocyte: 9 nTPM
  • MAIT T-cell: 8.4 nTPM

Brain region

  • midbrain: 5.6 nTPM
  • pons: 5.4 nTPM
  • thalamus: 5.4 nTPM
  • hypothalamus: 5.3 nTPM
  • medulla oblongata: 5.3 nTPM
  • choroid plexus: 5.2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about TRMU.

Disease | AllUniProt

Conditions TRMU is implicated in, by any mechanism.

Disease | GeneticClinVar

171 pathogenic / likely-pathogenic of 870 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.56
gnomAD pLI
0
gnomAD missense Z
-0.33
DepMap mean gene effect
0.12
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Rossmann-like alpha/beta/alpha sandwich fold
  • tRNA-specific 2-thiouridylase MnmA-like
  • tRNA-specific 2-thiouridylase MnmA-like, central domain superfamily
  • tRNA-specific 2-thiouridylase MnmA-like, central domain
  • tRNA-specific 2-thiouridylase MnmA-like, C-terminal domain
  • tRNA methyl transferase HUP domain
  • Aminomethyltransferase beta-barrel domain
  • tRNA methyl transferase PRC-barrel domain

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TRMU as an antibody target. Whether an autoantibody or antibody against TRMU could matter depends on whether native TRMU is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TRMU is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label TRMU as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TRMU. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...